Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ingrid Banovic"'
Autor:
Jessica Mange, Fabien Gierski, Ingrid Banovic, Hélène Beaunieux, Pierre Maurage, Mickaël Naassila, Séverine Lannoy, Delphine Grynberg
Publikováno v:
Alcohol and Alcoholism
Alcohol and Alcoholism, Oxford University Press (OUP), 2020, 55 (5), pp.468-479. ⟨10.1093/alcalc/agaa041⟩
Alcohol and Alcoholism, Oxford University Press (OUP), 2020, 2020, pp.468-479
Alcohol and Alcoholism, 2020, 55 (5), pp.468-479. ⟨10.1093/alcalc/agaa041⟩
Alcohol and Alcoholism, Oxford University Press (OUP), 2020, 55 (5), pp.468-479. ⟨10.1093/alcalc/agaa041⟩
Alcohol and Alcoholism, Oxford University Press (OUP), 2020, 2020, pp.468-479
Alcohol and Alcoholism, 2020, 55 (5), pp.468-479. ⟨10.1093/alcalc/agaa041⟩
Rationale Binge drinking (BD), characterized by recurring alternations between intense intoxication episodes and abstinence periods, is the most frequent alcohol consumption pattern in youth and is growing in prevalence among older adults. Many studi
Publikováno v:
J Crohns Colitis
J Crohns Colitis, 2011, 6 (5), pp.571-577. 〈10.1016/j.crohns.2011.11.006〉
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2012, 6 (5), pp.571-577. ⟨10.1016/j.crohns.2011.11.006⟩
Journal of Crohn's and Colitis, 2012, 6 (5), pp.571-577. ⟨10.1016/j.crohns.2011.11.006⟩
J Crohns Colitis, 2011, 6 (5), pp.571-577. 〈10.1016/j.crohns.2011.11.006〉
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2012, 6 (5), pp.571-577. ⟨10.1016/j.crohns.2011.11.006⟩
Journal of Crohn's and Colitis, 2012, 6 (5), pp.571-577. ⟨10.1016/j.crohns.2011.11.006⟩
International audience; BACKGROUND AND AIMS: Fatigue is considered as a feature of IBD. Nevertheless, medical variables would partly explain this complex phenomenon. Psychological variables would be especially connected to fatigue for patients in rem
Publikováno v:
Traffic
Traffic, Wiley, 2009, 3 ((1)), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2008, pp.Ms. Ref. No. CROHNS-D-08-00028R1. 〈10.1016/j.crohns.2008.10.003〉
Traffic, 2009, 3 ((1)), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2008, pp.Ms. Ref. No. CROHNS-D-08-00028R1. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2009, 3 (1), pp.25-31
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2009, 3 (1), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Traffic, Wiley, 2009, 3 ((1)), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2008, pp.Ms. Ref. No. CROHNS-D-08-00028R1. 〈10.1016/j.crohns.2008.10.003〉
Traffic, 2009, 3 ((1)), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2008, pp.Ms. Ref. No. CROHNS-D-08-00028R1. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2009, 3 (1), pp.25-31
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2009, 3 (1), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
International audience; UNLABELLED: BACKGROUND AND AIMS AND METHOD: Although Infliximab is a very potent therapy of refractory Crohn's disease, its administration requires iterative infusions in hospital and there are concerns regarding its long-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a7e20f8ce1a5f47937e8cb797c2347
https://hal.archives-ouvertes.fr/hal-00944395
https://hal.archives-ouvertes.fr/hal-00944395